• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·N. Zealand·Consumer Cyclical·MEE.NZ
Share

Me Today Limited Stocks

NZ$ 0.11Last Updated 21.09.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

NZ$ 3.81M

NZ$ 0.11
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Based in Auckland, New Zealand, Me Today Limited, through its various subsidiaries, is dedicated to the creation, distribution, and promotion of health and wellness products. The company offers a comprehensive range of dietary supplements designed to support general health, bone and muscle strength, healthy skin and veins, energy production, urinary tract function, and the vitality of hair, skin, and nails. In addition to supplements, its portfolio includes a selection of skincare products such as cream cleansers, moisturizers, serums, eye and night creams, and face masks. These offerings are marketed under the company's flagship "Me Today" brand, as well as other proprietary labels. Founded in 2007, Me Today Limited operates as a subsidiary of Mtl Securities Limited.

Company Valuation

Overvalued
2/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

21.09.2026 15:37

Morning in New York: Optimism Drives Market Prices

21.09.2026 14:53

German stocks rose despite the chancellor's party's poor showing in the election. What's going on?

21.09.2026 14:03

Facebook and Instagram experienced an outage in the U.S.

21.09.2026 13:41

Poland Has Emerged From a 19-Year Stagnation: What Is Driving the Growth of Its Economy and Market

21.09.2026 13:15

"Zero Risk," Sanctions, and AI: Highlights from Revolut CEO's Interview with the Financial Times

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026